Antipsychotic medications are commonly used across a wide range of age groups for conditions such as schizophrenia, bipolar disorder, behavioral and psychological symptoms of dementia (BPSD), and other psychiatric disorders. Understanding why antipsychotic risks are different in elderly patients compared with adults in their 20s and 30s is critical for safe prescribing and monitoring.
The Older Adult and Polypharmacy
In general, antipsychotics carry more risk in elderly patients. I say that with the caveat of recognizing that the dose of a medication matters. Often in younger schizophrenic patients we have to use higher dosages of antipsychotics, which can increase the risk for dose-dependent effects. With that caveat, one of the primary reasons antipsychotics carry greater risks in older adults is the physiologic changes that occur with aging. Elderly patients often experience:
- Reduced renal function
- Reduced hepatic metabolism
- Increased body fat percentage
- Decreased total body water
- Increased sensitivity to central nervous system medications
These changes can lead to higher drug concentrations, prolonged drug exposure, and greater susceptibility to adverse effects even when standard doses are used. The aging body, in association with patients typically taking more medications that may interact, can potentially lead to drug interactions and higher drug concentrations.
A 25-year-old patient may tolerate a moderate dose of an antipsychotic without significant issues, while the same dose could produce excessive sedation, confusion, or falls in an 85-year-old patient.
Increased Risk of Falls
Falls are among the most common and clinically significant complications associated with antipsychotic use in older adults. This concern is much more significant in older adults than it is in younger adults.
Many antipsychotics can cause:
- Sedation
- Orthostatic hypotension
- Impaired balance
- Slowed reaction time
Orthostasis is something to monitor. Clozapine typically is not used in geriatrics, but is the highest risk agent for causing orthostasis. This is primarily because it has a high level of alpha-blocking activity (excellent board exam question). While quetiapine has a lower incidence of EPS adverse effects, it is considered a higher risk agent for causing orthostasis. This is an important monitoring parameter when quetiapine is used.
Younger adults generally have greater physiologic reserve and are less likely to experience serious consequences from mild dizziness or orthostasis.
Higher Risk of Cognitive Impairment
Antipsychotics can worsen cognition, particularly in patients with dementia. While younger patients may experience some cognitive slowing, they typically have sufficient cognitive reserve to compensate. Elderly patients, especially those with underlying dementia, often have little reserve remaining, making them far more vulnerable to cognitive decline.
While all antipsychotics can potentially cause cognitive impairment, the highest risk agent is clozapine due to its higher anticholinergic burden. Olanzapine, while less than clozapine, has a moderate level of anticholinergic activity as well.
Increased Mortality in Dementia
Perhaps the most well-known warning associated with antipsychotic use in elderly patients is the FDA boxed warning regarding increased mortality in patients with dementia-related psychosis.
This mortality signal has not been observed to the same degree in younger adults receiving antipsychotics for approved psychiatric indications. As a result, clinicians should carefully evaluate whether the benefits justify the risks when antipsychotics are considered for behavioral symptoms associated with dementia.
Metabolic Effects in Younger Adults
While elderly patients face numerous age-related risks of antipsychotics, younger adults often experience different concerns. The metabolic effects of higher-dose antipsychotics over long periods of time can be much more concerning in younger patients.
In patients in their 20s and 30s, clinicians frequently focus on:
- Weight gain
- Diabetes risk
- Dyslipidemia
- Long-term cardiovascular disease
- Sexual dysfunction
- Hyperprolactinemia
These adverse effects remain important in older adults but are often overshadowed by more immediate concerns such as falls, stroke risk, and mortality.
0 Comments